LifeMD, Inc. — Director's Dealing 2022

Jan 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2022-01-27

Reporting Person: Yecies Eric Harold (General Counsel & CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-27	Common Stock	M	12500	—	Acquired	46000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-27	Restricted Stock Unit	$0	A	37500	Acquired		Common Stock (37500)	Direct
2022-01-27	Restricted Stock Unit	$	M	12500	Disposed		Common Stock (12500)	Direct

Footnotes

F1: 12,500 RSUs vested on January 27, 2022. Of the remaining RSUs, 12,500 vest on January 27, 2023 and 12,500 RSUs vest on January 27, 2024.

F2: Restricted stock units convert in common stock on a one-for-one basis.